A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (50 mg, 100 mg) of Desvenlafaxine Sustained-Release Tablets in Adult Outpatients With Major Depressive Disorder
收藏DataCite Commons2025-11-24 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005333/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective is to compare the antidepressant efficacy, safety, and tolerability of DVS SR versus placebo in subjects with Major Depressive Disorder. Additional objectives include testing both general and functional quality-of-life outcomes and satisfaction with therapy reported by the subject.
提供机构：
Vivli
创建时间：
2020-03-23
